Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

BACKGROUND: Chronic kidney disease (CKD) is a risk factor for end-stage renal failure and cardiovascular disease, and a strategy to counteract CKD must be established. CKD caused by immunological abnormalities is treated by steroids, frequently resulting in steroid diabetes. Although insulin is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohashi, Naro, Tsuji, Naoko, Naito, Yoshitaka, Iwakura, Takamasa, Isobe, Shinsuke, Ono, Masafumi, Fujikura, Tomoyuki, Tsuji, Takayuki, Sakao, Yukitoshi, Yasuda, Hideo, Kato, Akihiko, Fujigaki, Yoshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989946/
https://www.ncbi.nlm.nih.gov/pubmed/24717767
http://dx.doi.org/10.12659/MSM.889872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989946/
https://www.ncbi.nlm.nih.gov/pubmed/24717767
http://dx.doi.org/10.12659/MSM.889872

Ejemplares similares